Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
30.9M
-
Number of holders
-
217
-
Total 13F shares, excl. options
-
29.1M
-
Shares change
-
+1.84M
-
Total reported value, excl. options
-
$2.42B
-
Value change
-
+$177M
-
Put/Call ratio
-
0.66
-
Number of buys
-
121
-
Number of sells
-
-85
-
Price
-
$83.18
Significant Holders of CONMED Corp - Common Stock (CNMD) as of Q1 2019
245 filings reported holding CNMD - CONMED Corp - Common Stock as of Q1 2019.
CONMED Corp - Common Stock (CNMD) has 217 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.1M shares
of 30.9M outstanding shares and own 93.99% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.19M shares), VANGUARD GROUP INC (2.77M shares), Capital Research Global Investors (1.9M shares), DIMENSIONAL FUND ADVISORS LP (1.5M shares), Champlain Investment Partners, LLC (1.43M shares), STATE STREET CORP (999K shares), GOLDMAN SACHS GROUP INC (811K shares), MACQUARIE GROUP LTD (803K shares), Point72 Asset Management, L.P. (748K shares), and NORTHERN TRUST CORP (603K shares).
This table shows the top 217 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.